Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$119K Sell
7,024
-1,331
-16% -$26.2K 0.01% 1421
2015
Q2
$149K Buy
8,355
+926
+12% +$16K 0.01% 1366
2015
Q1
$130K Buy
7,429
+1,034
+16% +$18.9K 0.01% 1424
2014
Q4
$119K Sell
6,395
-416
-6% -$6.84K 0.01% 1422
2014
Q3
$101K Buy
6,811
+214
+3% +$3.38K 0.01% 1442
2014
Q2
$100K Buy
6,597
+1,434
+28% +$21.3K 0.01% 1448
2014
Q1
$87K Buy
5,163
+686
+15% +$11.2K 0.01% 1466
2013
Q4
$77K Buy
4,477
+173
+4% +$3.01K 0.01% 1499
2013
Q3
$65K Sell
4,304
-340
-7% -$4.86K 0.01% 1485
2013
Q2
$65K Buy
+4,644
New +$61.3K 0.01% 1435

Other funds holding NEOG

OFI Advisors's NEOG Position: Q3 2015 in Review

OFI Advisors reduced its Neogen (NEOG) stake by 16% in Q3 2015, selling an estimated $26.2K and leaving 7,024 shares worth $119K. The position accounts for 0.01% of the portfolio, ranked #1421.

OFI Advisors first reported a position in NEOG in Q2 2013 and has held it in 10 quarters since. The position peaked at $149K in Q2 2015. 205 funds tracked by Wall St. Rank hold NEOG as of Q3 2015.

  • OFI Advisors held 7,024 shares of Neogen worth $119K as of Q3 2015.
  • OFI Advisors sold 1,331 Neogen shares in Q3 2015, an estimated $26.2K.
  • Neogen made up 0.01% of OFI Advisors's portfolio in Q3 2015, its #1421 holding.
  • OFI Advisors first reported a position in Neogen in Q2 2013 and has held it in 10 quarters since.
  • OFI Advisors's Neogen position peaked at $149K in Q2 2015.
  • 205 funds tracked by Wall St. Rank held Neogen as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.